Position in PGEN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$666,694
+$407,082 QoQ
Shares Held
116,964
-36.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#83
of 210 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. PGEN ranks #55 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IOVA |
Iovance Biotherapeutics, Inc.
|
655,318 | $2,726,122 | |
| 2 | IMVT |
Immunovant, Inc.
|
65,267 | $2,514,737 | |
| 3 | GOSS |
Gossamer Bio, Inc.
|
14,986,947 | $2,472,846 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,419 | $2,305,488 | |
| 5 | CABA |
Cabaletta Bio, Inc.
|
668,563 | $2,079,230 | |
| 6 | MLTX |
MoonLake Immunotherapeutics
|
106,695 | $2,077,351 | |
| 7 | ATYR |
aTYR PHARMA INC
|
3,454,863 | $2,062,553 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
23,257 | $2,022,196 |
All Filings in PGEN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $666,694 | 116,964 | Shares | Sole | 2026-08-06 | |
| 2025-06-30 | $259,612 | 182,826 | Shares | Sole | 2025-07-22 | |
| 2024-06-30 | $120,757 | 76,429 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $323,767 | 223,288 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $765,760 | 571,463 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $475,400 | 334,789 | Shares | Sole | 2023-11-15 | |
| 2023-03-31 | $289,067 | 272,705 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $376,876 | 247,945 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $766,483 | 361,549 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $672,413 | 501,801 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $695,958 | 329,838 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $480,255 | 129,449 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $156,416 | 31,346 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $264,139 | 25,896 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $692,027 | 197,722 | Shares | Sole | 2020-11-06 | |
| 2020-03-31 | $432,017 | 127,064 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||